BCYC - Bicycle Therapeutics GAAP EPS of -$1.01 beats by $0.05 revenue of $3.19M misses by $0.56M
- Bicycle Therapeutics press release ( NASDAQ: BCYC ): Q4 GAAP EPS of -$1.01 beats by $0.05 .
- Revenue of $3.19M (-15.4% Y/Y) misses by $0.56M .
For further details see:
Bicycle Therapeutics GAAP EPS of -$1.01 beats by $0.05, revenue of $3.19M misses by $0.56M